Suppr超能文献

促性腺激素表达异常所致的骨表型:促性腺激素在绝经后骨质疏松症中的作用。

Bone phenotypes in response to gonadotropin misexpression: the role for gonadotropins in postmenopausal osteoporosis.

机构信息

Department of Oral and Dental Sciences, Division of Oral Medicine, University of Bristol Dental School, Lower Maudlin Street, Bristol, BS1 2LY, UK.

出版信息

Int J Gen Med. 2008 Nov 30;1:51-7. doi: 10.2147/ijgm.s3879.

Abstract

Scant attention has been paid to the potential role of gonadotropins in bone tissue homeostasis. The focus on estrogen and estrogen replacement therapy for osteoporosis as far back as the 1940's may account for the paucity of gonadotropin studies in bone biology. It is conceivable that prevailing dogma may have subconsciously steered us away from addressing whether gonadotropins have a place in skeletal physiology. However an examination of bone tissue catabolism in ovariectomized (OVX) and luteinizing hormone-releasing hormone (LHRH) agonist (Zoladex((R)))-treated rats generated some interesting and conflicting data; Zoladex-treated rats, unlike the OVX group, failed to exhibit increased bone collagen catabolism despite clear evidence for estrogen deficiency. The findings, although controversial, supported the possibility that elevated gonadotropins in the OVX model were in some way accountable for increased bone catabolism. In response to these initial findings further studies were performed to determine if altered LH status may in some way impact on the skeleton To this end an investigation of bone mass and histomorphometry were conducted in LH receptor nullizygous mice and human chorionic gonadotropin (hCG) overexpressing mice. There were clear phenotypic differences; the LH receptor knockout mice displayed reduced bone mass whereas the hCG overexpressing animals had stark increases in bone mass. Much more recently the team of the Mount Sinai Bone Program have made a significant discovery that bone-resorbing osteoclasts express receptors for follicle-stimulating hormone (FSH) and that mice nullizygous for FSH receptor are resistant to bone loss despite severe estrogen deficiency. Details of these fascinating models will be presented together with additional findings that give credence for exploring gonadotropin action on the skeleton as we enter the twilight of this Decade of the Bone and Joint.

摘要

人们对促性腺激素在骨组织稳态中的潜在作用关注甚少。早在 20 世纪 40 年代,人们就将注意力集中在雌激素和雌激素替代疗法上,以治疗骨质疏松症,这可能是导致骨生物学中促性腺激素研究较少的原因。可以想象,流行的观念可能在潜意识中引导我们不去探讨促性腺激素在骨骼生理学中的作用。然而,对去卵巢(OVX)和促黄体生成素释放激素(LHRH)激动剂(Zoladex((R)))治疗的大鼠的骨组织分解代谢的检查产生了一些有趣且相互矛盾的数据;与 OVX 组不同,Zoladex 治疗的大鼠尽管有明确的雌激素缺乏证据,但并未表现出骨胶原分解代谢增加。这些发现虽然存在争议,但支持了这样一种可能性,即在 OVX 模型中升高的促性腺激素在某种程度上解释了骨分解代谢的增加。

为了应对这些初步发现,进行了进一步的研究,以确定 LH 状态的改变是否会以某种方式影响骨骼。为此,对 LH 受体缺失杂合子小鼠和人绒毛膜促性腺激素(hCG)过表达小鼠的骨量和组织形态计量学进行了研究。结果显示,LH 受体敲除小鼠的骨量减少,而 hCG 过表达动物的骨量明显增加。最近,西奈山骨计划的研究小组取得了一项重大发现,即破骨细胞表达卵泡刺激素(FSH)受体,并且 FSH 受体缺失的小鼠尽管雌激素严重缺乏,但仍能抵抗骨丢失。这些迷人模型的详细信息将与其他发现一起呈现,这些发现为探索促性腺激素对骨骼的作用提供了依据,因为我们即将进入这个骨与关节的十年的尾声。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2669/2840536/7c9ef00bcbcf/ijgm-1-51f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验